- Human pathology

Home > G. Tumoral pathology > Molecular pathology of tumors > Liquid biopsy > Circulating tumor cells > CTCs by cancer > Circulating tumor cells in prostate cancer

Circulating tumor cells in prostate cancer

Friday 29 November 2013

CTCs in prostate carcinoma

Open references

- Circulating tumor cells as biomarkers in prostate cancer. Danila DC, Fleisher M, Scher HI. Clin Cancer Res. 2011 Jun 15;17(12):3903-12. doi : 10.1158/1078-0432.CCR-10-2650 PMID: 21680546 [Free]

- TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate. Danila DC, Anand A, Sung CC, Heller G, Leversha MA, Cao L, Lilja H, Molina A, Sawyers CL, Fleisher M, Scher HI. Eur Urol. 2011 Nov;60(5):897-904. doi : 10.1016/j.eururo.2011.07.011 PMID: 21802835 [Free]

- Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E, Lilja H, Schwartz L, Larson S, Fleisher M, Scher HI. Clin Cancer Res. 2007 Dec 1;13(23):7053-8. PMID: #18056182 [Free]

- Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. Leversha MA, Han J, Asgari Z, Danila DC, Lin O, Gonzalez-Espinoza R, Anand A, Lilja H, Heller G, Fleisher M, Scher HI. Clin Cancer Res. 2009 Mar 15;15(6):2091-7. doi : 10.1158/1078-0432.CCR-08-2036 PMID: 19276271 [Free]

- Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. Helo P, Cronin AM, Danila DC, Wenske S, Gonzalez-Espinoza R, Anand A, Koscuiszka M, Väänänen RM, Pettersson K, Chun FK, Steuber T, Huland H, Guillonneau BD, Eastham JA, Scardino PT, Fleisher M, Scher HI, Lilja H. Clin Chem. 2009 Apr;55(4):765-73. doi : 10.1373/clinchem.2008.117952 PMID: 19233911 [Free]

- Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Scher HI, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghavan D, Heller G. Lancet Oncol. 2009 Mar;10(3):233-9. doi : 10.1016/S1470-2045(08)70340-1 PMID: 19213602 [Free]

- Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Shaffer DR, Leversha MA, Danila DC, Lin O, Gonzalez-Espinoza R, Gu B, Anand A, Smith K, Maslak P, Doyle GV, Terstappen LW, Lilja H, Heller G, Fleisher M, Scher HI. Clin Cancer Res. 2007 Apr 1;13(7):2023-9. PMID: 17404082 [Free]


- Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer. Ligthart ST, Coumans FA, Bidard FC, Simkens LH, Punt CJ, de Groot MR, Attard G, de Bono JS, Pierga JY, Terstappen LW. PLoS One. 2013 Jun 27;8(6):e67148. Print 2013. PMID: 23826219 [Free]

- mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. Cann GM, Gulzar ZG, Cooper S, Li R, Luo S, Tat M, Stuart S, Schroth G, Srinivas S, Ronaghi M, Brooks JD, Talasaz AH. PLoS One. 2012;7(11):e49144. doi : 10.1371/journal.pone.0049144 PMID: 23145101 [Free]

- Detection of circulating tumor cells in different stages of prostate cancer. Thalgott M, Rack B, Maurer T, Souvatzoglou M, Eiber M, Kreß V, Heck MM, Andergassen U, Nawroth R, Gschwend JE, Retz M. J Cancer Res Clin Oncol. 2013 May;139(5):755-63. doi : 10.1007/s00432-013-1377-5 PMID: 23358719

- The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer. Pantel K, Alix-Panabières C. Cancer Discov. 2012 Nov;2(11):974-5. doi : 10.1158/2159-8290.CD-12-0432 PMID: 23093252